Cyanine7.5 carboxylic acid
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 16090 | 1 mg | $110.00 | in stock | |
| 26090 | 5 mg | $210.00 | in stock | |
| 46090 | 25 mg |
$410.00
|
in stock | |
| 56090 | 50 mg |
$695.00
|
in stock | |
| 66090 | 100 mg |
$1190.00
|
in stock |
Free unactivated Cyanine7.5 NIR dye carboxylic acid.
For coupling and labeling reactions also consider using pre-activated Cyanine7.5 NHS ester.
Cy7.5 absorbance and emission spectra
Customers also purchased with this product
Biotin PEG3 azide
Biotin azide is a reagent for click chemistry labeling with biotin, a well-known affinity probe.Cyanine3 NHS ester
Amine-reactive Cyanine3 dye NHS ester.Copper(II)-TBTA complex, 10 mM in 55% aq. DMSO
Catalyst for bioconjugate synthesis by Click Chemistry.General properties
| Appearance: | green powder |
| Molecular weight: | 685.34 |
| CAS number: | 1686147-68-1, 1803099-44-6 [Cl-] |
| Molecular formula: | C45H49ClN2O2 |
| Solubility: | soluble in organic solvents (DMSO, DMF, dichloromethane), low solubility in water |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation maximum, nm: | 788 |
| ε, L⋅mol−1⋅cm−1: | 223000 |
| Emission maximum, nm: | 808 |
Product citations
- Yen, H.-C.; Kuo, T.-R.; Huang, M.-H.; Huang, H.-K.; Chen, C.-C. Design of Fluorescence-Enhanced Silver Nanoisland Chips for High-Throughput and Rapid Arsenite Assay. ACS Omega, 2020, 5(31), 19771–19777. doi: 10.1021/acsomega.0c02533
- Matoori, S.; Mooney, D.J. Near-Infrared Fluorescence Hydrogen Peroxide Assay for Versatile Metabolite Biosensing in Whole Blood. Small, 2020, 16(20), 2000369. doi: 10.1002/smll.202000369
- DuRoss, A.N.; Neufeld, M.J.; Landry, M.R.; Rosch, J.G.; Eaton, C.T.; Sahay, G.; Thomas, C.R.; Sun, C. Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy. ACS Applied Materials & Interfaces, 2019, 11(13), 12342–12356. doi: 10.1021/acsami.9b02408
- Howard, G.P.; Verma, G.; Ke, X.; Thayer, W.M.; Hamerly, T.; Baxter, V.K.; Lee, J.E.; Dinglasan, R.R.; Mao, H.-Q. Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration. Nano Research, 2019, 12(4), 837–844. doi: 10.1007/s12274-019-2301-3
Cy® is a trademark of GE Healthcare.
The count of items is incorrect.
Your cart is empty
$ 
